Home » Authors » Anette Breindl

Articles by Anette Breindl

Gene Therapy Heals Cells, Hearing In Deaf Guinea Pigs

March 7, 2005

By Anette Breindl

Gene Therapy Heals Cells, Hearing In Deaf Guinea Pigs

March 7, 2005

By Anette Breindl

In CF, Smaller Promoter Makes A Better Gene Therapy Vehicle

March 1, 2005

By Anette Breindl

In CF, Smaller Promoter Makes A Better Gene Therapy Vehicle

March 1, 2005

By Anette Breindl

Aggressive HIV Strain: Assay Possibilities, Case Study Limits

Feb. 28, 2005

By Anette Breindl

Aggressive HIV Strain: Assay Possibilities, Case Study Limits

Feb. 28, 2005

By Anette Breindl

Feeding Trash To Plants For A Greener Pollution Solution

Feb. 24, 2005

By Anette Breindl

Feeding Trash To Plants For A Greener Pollution Solution

Feb. 24, 2005

By Anette Breindl

Combinatorial Approach Flies Against Huntington's Disease

Feb. 22, 2005

By Anette Breindl

Combinatorial Approach Flies Against Huntington's Disease

Feb. 22, 2005

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...